Guangzhou
Guangzhou
Guangzhou, Guangdonng, China1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of PM8002 (Anti-PD-L1/VEGF) in Combination With Chemotherapy in Patients With NSCLC | non-small cell lung carcinoma | Active, not recruiting | Phase 2 | 2025-04-03 | NCT05756972 |